Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MO/Kansas City
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kansas City, MO

Studies commonly pay $75 to $4,500 per completed study

1,018 clinical trials are currently recruiting participants within 30 miles of Kansas City. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,018studies recruiting
9+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Kansas City right now

Top 25 of 1,018 recruiting studies, sorted by proximity — each links to its official registry page

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
Children's Mercy Hospital — Kansas City, Missouri (2.1 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Mercy Hospitals and Clinics — Kansas City, Missouri (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of Kansas Cancer Center — Westwood, Kansas (6.7 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Buntanetap in Participants With PD

Parkinson's Disease (PD), Deep Brain Stimulation Phase 2, Phase 3 Interventional 500 participants sought
University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D — Kansas City, Kansas (4.0 mi) · Sponsor: Annovis Bio Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284784)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
University of Kansas Cancer Center at North Kansas City Hospital — North Kansas City, Missouri (0.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
University of Kansas Medical Center — Kansas City, Kansas (4.0 mi) · Sponsor: AskBio Inc
See eligibility & contact on ClinicalTrials.gov (NCT05230459)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
St. Lukes Hospital of Kansas City — Kansas City, Missouri (2.1 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06625775)

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Colo-rectal Cancer Phase 2 Interventional 79 participants sought
University of Kansas Cancer Center — Kansas City, Kansas (4.0 mi) · Sponsor: NSABP Foundation Inc
See eligibility & contact on ClinicalTrials.gov (NCT07058012)

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Acute Ischemic Stroke N/A Interventional 408 participants sought
The University of Kansas Health System — Kansas City, Kansas (4.0 mi) · Sponsor: Amrou Sarraj
See eligibility & contact on ClinicalTrials.gov (NCT07115940)

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

HPV-unrelated Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 81 participants sought
Saint Luke's Hospital — Kansas City, Missouri (2.1 mi) · Sponsor: Washington University School of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT04966481)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A Observational 30 participants sought
University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas (4.0 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06538064)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
Johnson County Clinical Trials — Kansas City, Missouri (2.1 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Chronic Kidney Disease Phase 2 Interventional 465 participants sought
Clinical Research Consultants — Kansas City, Missouri (2.1 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06717698)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Kansas City, Kansas (4.0 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Liver Fibrosis, Hepatic Cirrhosis Phase 2 Interventional 104 participants sought
Research Site — Kansas City, Missouri (2.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07610837)

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

Myelodysplastic Syndrome, Acute Myeloid Leukemia Phase 1 Interventional 178 participants sought
The University of Kansas Cancer Center - Medical Oncology Clinic — Kansas City, Missouri (2.1 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04227847)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10002 Kansas City, MO Investigative Site — Kansas City, Missouri (2.1 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

Kidney Transplant Phase 2 Interventional 180 participants sought
Kansas University Medical Center — Kansas City, Kansas (4.0 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
See eligibility & contact on ClinicalTrials.gov (NCT06919003)

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis Phase 2 Interventional 180 participants sought
University of Kansas Medical Center Research Institute Inc. — Kansas City, Kansas (4.0 mi) · Sponsor: ACADIA Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07029581)

Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)

Complex Cardiovascular Surgery With Cardiopulmonary Bypass Phase 3 Interventional 200 participants sought
University of Kansas Medical Center (KUMC) — Kansas City, Kansas (4.0 mi) · Sponsor: CSL Behring
See eligibility & contact on ClinicalTrials.gov (NCT07094087)

Naltrexone Neuroimaging in Teens With Eating Disorders

Eating Disorders, Binge Eating EARLY/Phase 1 Interventional 60 participants sought
Children's Mercy Research Institute — Kansas City, Missouri (2.1 mi) · Sponsor: Children's Mercy Hospital Kansas City
See eligibility & contact on ClinicalTrials.gov (NCT05509257)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Kansas City, Kansas (4.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)
Actively enrolling

Studies you may be able to join near Kansas City

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Kansas City

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

KCU Dybedal Center

1750 Independence Ave, Kansas City, MO 64106
(800) 234-4847

Spectrum Clinical Research

★ 4.0
2700 Clay Edwards Dr #260, Kansas City, MO 64116
(816) 562-6466
"The staff are very friendly and professional. I was very pleased with service I received. I was treated with respect and they answered all of my ques…"
— Terri Carter, 4★

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

Qieon Research Laboratories

★ 5.0
405 Southwest Blvd #137 Floor 13, Kansas City, MO 64108
(913) 230-9170
"We have been following this company for a very long time. They have technological abilities that are indistinguishable from magic"
— Project Project, 5★

KCU: Dybedal Center for Research

1750 Independence Ave, Kansas City, MO 64106
(816) 654-7000

Kansas City Research Institute

★ 5.0
6667 Holmes Rd Ste 129, Kansas City, MO 64131
(816) 759-5274
"Professional, quick & efficient"
— Michael Fleschman, 5★

Clinical Research Consultants

★ 4.6
3930 Washington St, Kansas City, MO 64111
(816) 756-1222
"They are the best especially my girl chandrika.she comes with great medical knowledge.i recommend everyone to Check them out."
— Edna Yancy, 5★

The University of Kansas Clinical Research Center

★ 4.8 (6 reviews)
4350 Shawnee Mission Pkwy, Fairway, KS 66205
(913) 588-1227
"Westwood Internal Medicine is staffed with healthcare professionals who are well trained. Their credentials are impressive and well served to the hig…"
— Rebecca Jones, 5★

Children's Mercy Research Institute

★ 5.0
2401 Gillham Rd, Kansas City, MO 64108
(816) 234-3000
"Hospital Kids Children's Mercy"
— Leyela Long, 5★

Clinical trials in Kansas City: what's recruiting

The Kansas City area currently has 1,018 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kansas City, the most active research areas are:

  • Cancer & Oncology9 studies
  • Liver & Kidney4 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Kansas City, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kansas City

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kansas City participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Kansas City pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Kansas City?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Kansas City safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Kansas City?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Kansas City.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kansas City typically complete one or two studies per year.

Paid clinical trials near Kansas City

Other metros within reach

Kansas City, KS1,029 Overland Park, KS1,017 Olathe, KS1,025 Topeka, KS110 Columbia, MO253 Springfield, MO150 Omaha, NE594 Des Moines, IA222

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Kansas City Bladder Issues Due To Spinal Cord Injury in Kansas City All conditions

More of MO

St. Louis1,490 Columbia253 Springfield150

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts